A Biden administration proposal to extend Medicare and Medicaid coverage for weight-loss drugs like Wegovy awaits President-elect Trump’s approval.
The plan could grant access to millions but faces opposition from some of Trump’s advisors.
While public support for the measure remains strong, critics cite concerns about cost and long-term efficacy.
Trump’s team remains divided, with some advocating for alternative health initiatives over pharmaceutical solutions.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to news@fingerlakes1.com.